News
VenatoRx Receives $9.4 Million from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Drug Resistant Bacteria
VenatoRx Raises $42 Million Series B: Versant, Abingworth, Foresite Back Industry-Leading Antibiotics Developer
Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program
Bainbridge Health launches InfusionWare™ Intelligence to Address Medication Safety Practices
The One Health Company Teams with the Johns Hopkins University School of Medicine to Advance Sarcoma Treatment for Dogs and Humans